Rankings
▼
Calendar
HOTH Q2 2018 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOTH
Hoth Therapeutics, Inc.
$15M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$763,420
Net Income
-$763,420
EPS (Diluted)
$-2.03
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$597,222
Free Cash Flow
-$597,222
Stock-Based Comp.
$117,500
Balance Sheet
Total Assets
$1M
Total Liabilities
$128,908
Stockholders' Equity
$1M
Cash & Equivalents
$1M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$763,420
-$1M
+43.0%
Net Income
-$763,420
-$1M
+43.0%
← FY 2018
All Quarters
Q3 2018 →